T cell vaccination therapy in an induced model of anti-RNP autoimmune glomerulonephritis

Clinical Immunology

Volumn 137, Issue 2, 2010, Pages 281-287

  Trivedi, Sapna ^a   Zang, YunJuan ^b   Culpepper, Schartess ^b   Rosenbaum, Erica ^b   Fernandez, Irina ^b   Martinez, Laisel ^b   Hoffman, Robert W ^b   Greidinger, Eric L ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Lupus; Nephritis; Ribonucleoproteina; T cell; Therapy

Indexed keywords

RIBONUCLEOPROTEIN; SMALL NUCLEAR RIBONUCLEOPROTEIN; T LYMPHOCYTE RECEPTOR;

ALLERGIC GLOMERULONEPHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; T LYMPHOCYTE; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; COMPLEMENTARITY DETERMINING REGIONS; HLA-DR ANTIGENS; HUMANS; KIDNEY GLOMERULUS; LUPUS NEPHRITIS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECOMBINANT FUSION PROTEINS; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; SPLEEN; T-LYMPHOCYTES; URINALYSIS; VACCINATION;

EID: 77957313385     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.07.013     Document Type: Article

References (19)

1. Sharp G.C., Irvin W.S., May C.M., Holman H.R., McDuffie F.C., Hess E.V., Schmid F.R. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N. Engl. J. Med. 1976, 295:1149-1154.
2. Hoet R.M., Koornneef I., de Rooij D.J., van de Putte L.B., van Venrooij W.J. Changes in anti-U1 RNA antibody levels correlate with disease activity in patients with systemic lupus erythematosus overlap syndrome. Arthritis Rheum. 1992, 35:1202-1210.
3. Kirou K.A., Lee C., George S., Louca K., Peterson M.G., Crow M.K. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum. 2005, 52:1491-1503.
4. Hua J., Kirou K., Lee C., Crow M.K. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum. 2006, 54:1906-1916.
5. Cambridge G., Isenberg D.A., Edwards J.C., Leandro M.J., Migone T.S., Teodorescu M., Stohl W. B cell depletion therapy in systemic lupus erythematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response. Ann. Rheum. Dis. 2008, 67:1011-1016.
6. Muller S., Monneaux F., Schall N., Rashkov R.K., Oparanov B.A., Wiesel P., Geiger J.M., Zimmer R. Spliceosomal peptide P140 for immunotherapy of systemic lupus erythematosus: results of an early phase II clinical trial. Arthritis Rheum. 2008, 58:3873-3883.
7. Greidinger E.L., Foecking M.F., Schäfermeyer K.R., Bailey C.W., Primm S.L., Lee D.R., Hoffman R.W. T cell immunity in connective tissue disease patients targets the RNA binding domain of the U1-70kDa small nuclear ribonucleoprotein. J. Immunol. 2002, 169:3429-3437.
8. + T cells target epitopes residing within the RNA-binding domain of the U1-70-kDa small nuclear ribonucleoprotein autoantigen and have restricted TCR diversity in an HLA-DR4-transgenic murine model of mixed connective tissue disease. J. Immunol. 2008, 180:8444-8454.
9. De Silva-Udawatta M., Kumar S.R., Greidinger E.L., Hoffman R.W. Cloned human TCR from patients with autoimmune disease can respond to two structurally distinct autoantigens. J. Immunol. 2004, 172:3940-3947.
10. Greidinger E.L., Gazitt T., Jaimes K.F., Hoffman R.W. Human T cell clones specific for heterogeneous nuclear ribonucleoprotein A2 autoantigen from connective tissue disease patients assist in autoantibody production. Arthritis Rheum. 2004, 50:2216-2222.
11. Greidinger E.L., Zang Y., Fernandez I., Berho M., Nassiri M., Martinez L., Hoffman R.W. Tissue targeting of anti-RNP autoimmunity: effects of T cells and myeloid dendritic cells in a murine model. Arthritis Rheum. 2009, 60:534-542.
12. Chen G., Li N., Zang Y.C., Zhang D., He D., Feng G., Ni L., Xu R., Wang L., Shen B., Zhang J.Z. Vaccination with selected synovial T cells in rheumatoid arthritis. Arthritis Rheum. 2007, 56:453-463.
13. Fujii T., Okada M., Fujita Y., Sato T., Tanaka M., Usui T., Umehara H., Mimori T. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice. J. Autoimmun. 2009, 33:125-134.
14. Greidinger E.L., Zang Y., Jaimes K., Hogenmiller S., Nassiri M., Bejarano P., Barber G.N., Hoffman R.W. A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen. Arthritis Rheum. 2006, 54:661-669.
15. Talken B.L., Bailey C.W., Reardon S.L., Caldwell C.W., Hoffman R.W. Structural analysis of TCRalpha and beta chains from human T-Cell clones specific for small nuclear ribonucleoprotein polypeptides Sm-D, Sm-B and U1-70kDa: TCR complementarity determining region 3 usage appears highly conserved. Scand. J. Immunol. 2001, 54:204-210.
16. Greidinger E.L., Foecking M.F., Ranatunga S., Hoffman R.W. Apoptotic U1-70kD is antigenically distinct from the intact form of the U1-70-kD molecule. Arthritis Rheum. 2002, 46:1264-1269.
17. Schiffer L., Sinha J., Wang X., Huang W., von Gersdorff G., Schiffer M., Madaio M.P., Davidson A. Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J. Immunol. 2003, 171:489-497.
18. Borel Y., Lewis R.M., André-Schwartz J., Stollar B.D., Diener E. Treatment of lupus nephritis in adult (NZB+NZW)F1 mice by cortisone-facilitated tolerance to nucleic acid antigens. J. Clin. Invest. 1978, 61:276-286.
19. Appleby P., Webber D.G., Bowen J.G. Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development. Clin. Exp. Immunol. Dec 1989, 78(3):449-453.